Cart
sales@molnova.com
Fluvastatin sodium salt
CAS No. 93957-55-2
Fluvastatin sodium salt( Canef | Fluindostatin | Lescol XL | Lipaxan | Vastin | XU-62-320 | XU62320 )
Catalog No. M16723 CAS No. 93957-55-2
Fluvastatin sodium is a competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase (HMGCR).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | 40 | In Stock |
|
| 50MG | 57 | In Stock |
|
| 100MG | 79 | In Stock |
|
| 200MG | 111 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameFluvastatin sodium salt
-
NoteResearch use only, not for human use.
-
Brief DescriptionFluvastatin sodium is a competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase (HMGCR).
-
DescriptionFluvastatin sodium is a competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase (HMGCR), used to treat hypercholesterolemia and to prevent cardiovascular disease.(In Vitro):Fluvastatin sodium (XU 62320) is a competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase (HMGCR), the enzyme that catalyzes the conversion of HMG-CoA to mevalonic acid, the rate-limiting step in cholesterol biosynthesis. Human hepatocellular carcinoma cell (HCC) studies indicate that Fluvastatin induces G2/M phase arrest. In the presence of Fluvastatin (XU 62320), HCC cells show a decrease of Bcl-2 and procaspase-9 expression, and an increase in Bax, cleaved caspase-3, and cytochrome c. Fluvastatin (XU 62320) is antilipemic and is used to reduce plasma cholesterol levels and prevent cardiovascular disease.
-
In VitroFluvastatin sodium (XU 62320) is a competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase (HMGCR), the enzyme that catalyzes the conversion of HMG-CoA to mevalonic acid, the rate-limiting step in cholesterol biosynthesis. Human hepatocellular carcinoma cell (HCC) studies indicate that Fluvastatin induces G2/M phase arrest. In the presence of Fluvastatin (XU 62320), HCC cells show a decrease of Bcl-2 and procaspase-9 expression, and an increase in Bax, cleaved caspase-3, and cytochrome c. Fluvastatin (XU 62320) is antilipemic and is used to reduce plasma cholesterol levels and prevent cardiovascular disease.
-
In Vivo——
-
SynonymsCanef | Fluindostatin | Lescol XL | Lipaxan | Vastin | XU-62-320 | XU62320
-
PathwayMetabolic Enzyme/Protease
-
TargetHMGCR
-
RecptorHMG-CoA reductase
-
Research AreaMetabolic Disease
-
Indication——
Chemical Information
-
CAS Number93957-55-2
-
Formula Weight433.45
-
Molecular FormulaC24H25FNNaO4
-
Purity>98% (HPLC)
-
SolubilityWater: 1 mg/mL (2.3 mM); DMSO: 87 mg/mL (200.71 mM)
-
SMILESO=C([O-])C[C@@H](O)C[C@@H](O)/C=C/C(N1C(C)C)=C(C2=CC=C(F)C=C2)C3=C1C=CC=C3.[Na+]
-
Chemical Namesodium (3S,5R,E)-7-(3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl)-3,5-dihydroxyhept-6-enoate
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Dansette PM, et al. Exp Toxicol Pathol, 2000, 52(2), 145-148.
molnova catalog
related products
-
Rosuvastatin calcium
A potent, competitive inhibitor of HMG-CoA reductase (HMGCR) with IC50 of 11 nM.
-
Clinofibrate
Clinofibrate inhibits hydroxymethylglutaryl coenzyme A reductase (HMGCR) with IC50 of 0.47 mM.
-
Atorvastatin hemical...
A competitive inhibitor of HMG-CoA reductase (HMGCR) that acts as a lipid-lowering agent for prevention of events associated with cardiovascular disease.
